首页 > 最新文献

Journal of the International Association of Physicians in AIDS Care最新文献

英文 中文
Response to Letter to the Editor 对给编辑的信的回应
Pub Date : 2012-08-01 DOI: 10.1177/1545109712446921
J. Shuter
Dr Chitsaz points out several concerns about our study. Most of the criticism stems from the lack of follow-up data on the complete cohort. They are correct in pointing out that the final sample in study II represents just 57% of the original 84 participants enrolled in study I. Follow-up information on deceased or lost to follow-up participants was, by definition, unavailable. As a consequence, we were unable to comment on the correlation of adherence rates in these participants between the 2 studies. We agree with Dr Chitsaz that it is likely that these individuals had more advanced disease. It is also reasonable to consider that survivor bias may have selected for a cohort with better outcomes in study II. Whether those who died or were lost to follow-up would have had poorer correlation of adherence rates between the 2 time points is purely speculative. With regard to the participants who switched to new regimens, 11 of the 12 switched from twice-daily to once-daily regimens. In contrast to the remainder of the cohort, adherence rates among these 12 increased, although not significantly, from study I to study II. It is likely that the lack of significant correlation in adherence rates in these participants was due to the change in the dosing schedule. Certainly, an idealized version of this study would have collected a complete complement of data on all participants. Nonetheless, the correlation of adherence rates between the 2 studies in the final cohort was noteworthy, particularly among the best adherers. The substantial lost to follow-up rate was acknowledged in the Discussion section, but we thank Dr Chitsaz for pointing out several potential biases that attrition from the study may have engendered.
Chitsaz博士指出了我们研究的几个问题。大多数批评源于缺乏完整队列的后续数据。他们正确地指出,研究II的最终样本只代表了研究i中最初84名参与者的57%。根据定义,关于死亡或失去随访参与者的后续信息是不可获得的。因此,我们无法评论两项研究中这些参与者的依从率之间的相关性。我们同意Chitsaz博士的观点,这些人很可能患有更严重的疾病。我们也可以合理地考虑,在研究II中,幸存者偏倚可能选择了一个结果更好的队列。是否那些死亡或失去随访的人在两个时间点之间的依从率相关性较差纯粹是推测。至于改用新方案的参与者,12人中有11人从每日两次改为每日一次。与其他队列相比,从研究1到研究2,这12人的依从率虽然不显著,但有所增加。在这些参与者中,依从率缺乏显著相关性可能是由于给药计划的改变。当然,这项研究的理想版本应该收集了所有参与者的完整数据。尽管如此,在最后的队列中,两项研究的依从率之间的相关性是值得注意的,特别是在最好的依从者中。讨论部分承认了随访率的实质性损失,但我们感谢Chitsaz博士指出了研究流失可能产生的几个潜在偏差。
{"title":"Response to Letter to the Editor","authors":"J. Shuter","doi":"10.1177/1545109712446921","DOIUrl":"https://doi.org/10.1177/1545109712446921","url":null,"abstract":"Dr Chitsaz points out several concerns about our study. Most of the criticism stems from the lack of follow-up data on the complete cohort. They are correct in pointing out that the final sample in study II represents just 57% of the original 84 participants enrolled in study I. Follow-up information on deceased or lost to follow-up participants was, by definition, unavailable. As a consequence, we were unable to comment on the correlation of adherence rates in these participants between the 2 studies. We agree with Dr Chitsaz that it is likely that these individuals had more advanced disease. It is also reasonable to consider that survivor bias may have selected for a cohort with better outcomes in study II. Whether those who died or were lost to follow-up would have had poorer correlation of adherence rates between the 2 time points is purely speculative. With regard to the participants who switched to new regimens, 11 of the 12 switched from twice-daily to once-daily regimens. In contrast to the remainder of the cohort, adherence rates among these 12 increased, although not significantly, from study I to study II. It is likely that the lack of significant correlation in adherence rates in these participants was due to the change in the dosing schedule. Certainly, an idealized version of this study would have collected a complete complement of data on all participants. Nonetheless, the correlation of adherence rates between the 2 studies in the final cohort was noteworthy, particularly among the best adherers. The substantial lost to follow-up rate was acknowledged in the Discussion section, but we thank Dr Chitsaz for pointing out several potential biases that attrition from the study may have engendered.","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"11 1","pages":"219 - 219"},"PeriodicalIF":0.0,"publicationDate":"2012-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109712446921","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5th International Conference on HIV TREATMENT ADHERENCE 第五届艾滋病治疗依从性国际会议
Pub Date : 2010-07-01 DOI: 10.1177/1545109710376486
{"title":"5th International Conference on HIV TREATMENT ADHERENCE","authors":"","doi":"10.1177/1545109710376486","DOIUrl":"https://doi.org/10.1177/1545109710376486","url":null,"abstract":"","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"9 1","pages":"240 - 267"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109710376486","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Promoting HIV Literacy 推广爱滋病知识
Pub Date : 2008-09-01 DOI: 10.1177/1545109708326073
J. Zuniga
H ealth literacy has a significant impact on our daily lives, affecting almost every aspect of our ability to understand and process information regarding our health. According to the American Medical Association (AMA), poor health literacy is ‘‘a stronger predictor of a person’s health than age, income, employment status, education level, and race.’’ In Health Literacy: A Prescription to End Confusion, the Institute of Medicine (IOM) reported that 90 million people in the United States, nearly half the population, have difficulty understanding and using health information. As a result, patients often take medicines on erratic schedules, miss follow-up appointments, and/or do not understand instructions such as ‘‘take on an empty stomach.’’ There are various examples of low health literacy’s impact. For example, a study of 483 asthma patients found that although two thirds reported graduating from high school, only 60% could read above the sixth-grade level. Reading ability was the single strongest predictor of asthma knowledge. Twice as many patients reading below the third-grade level had poor metered-dose inhaler technique as patients reading at high-school level (89% vs. 48%). And in a study involving 659 public hospital patients, those with poor health literacy skills were 5 times more likely to misinterpret their prescriptions than those with adequate skills. Likewise, in the management of HIV disease, a patient’s level of HIV literacy is critical for treatment success, one of the most important predictors of which is levels of adherence to antiretroviral therapy. A study of 182 HIV-positive adults found that those with low health literacy were more likely to miss doses than those with high health literacy because of confusion about the instructions. Yet another study involving 204 HIV-positive patients showed that low HIV literacy doubled the likelihood of nonadherence to antiretroviral therapy. Low HIV literacy was also demonstrated in the recent AIDS Treatment for Life International Survey (ATLIS), the results of which were published in the July/August 2008 issue of the Journal of the International Association of Physicians in AIDS Care (JIAPAC). This multicountry survey of almost 3000 HIV-positive patients from 6 geographical regions identified some major gaps in HIV literacy. When respondents were asked to describe how HIV drug resistance develops, for example, only 17% accurately answered the question; a total of 54% answered incorrectly or did not know the answer and 29% provided only partially accurate answers. North American (48%) and Asian/Pacific (20%) respondents were most likely to select the correct answer to the question, whereas African respondents were more likely to select an inaccurate answer or did not know (79%), followed by respondents from Latin America (58%) and Europe (54%). Previous studies have shown a strong correlation between a good understanding of HIV drug resistance and improved treatment adherence. Among th
健康素养对我们的日常生活有着重大的影响,影响着我们理解和处理健康信息的能力的几乎每一个方面。根据美国医学协会(AMA)的说法,糟糕的健康素养“比年龄、收入、就业状况、教育水平和种族更能预测一个人的健康状况”。在《健康素养:结束困惑的处方》一书中,医学研究所(IOM)报告称,美国有9000万人(近一半人口)在理解和使用健康信息方面存在困难。因此,患者经常不定期服药,错过随访预约,和/或不理解诸如“空腹服药”之类的说明。“卫生知识普及程度低的影响有很多例子。例如,一项对483名哮喘患者的研究发现,尽管三分之二的人报告从高中毕业,但只有60%的人能够阅读六年级以上的水平。阅读能力是哮喘知识的单一最强预测因子。读数低于三年级水平的患者计量吸入器技术较差的比例是阅读水平为高中的患者的两倍(89%对48%)。在一项涉及659名公立医院患者的研究中,那些卫生知识技能差的人误解处方的可能性是那些技能足够的人的5倍。同样,在艾滋病毒疾病的管理中,患者的艾滋病毒知识水平对治疗成功至关重要,其中最重要的预测因素之一是坚持抗逆转录病毒治疗的程度。一项对182名艾滋病毒阳性成年人的研究发现,由于对说明的混淆,健康知识水平低的人比健康知识水平高的人更有可能错过剂量。然而,另一项涉及204名艾滋病毒阳性患者的研究表明,低艾滋病毒识字率使不坚持抗逆转录病毒治疗的可能性增加了一倍。最近的艾滋病生命治疗国际调查(ATLIS)也证明了低艾滋病毒识字率,其结果发表在2008年7月/ 8月的国际艾滋病护理医师协会(JIAPAC)杂志上。这项对来自6个地理区域的近3000名艾滋病毒阳性患者进行的多国调查确定了艾滋病毒扫盲方面的一些主要差距。例如,当被要求描述艾滋病毒耐药性如何产生时,只有17%的人准确回答了这个问题;共有54%的人回答错误或不知道答案,29%的人只提供了部分准确的答案。北美(48%)和亚太地区(20%)的受访者最有可能选择正确的答案,而非洲受访者更有可能选择不准确的答案或不知道(79%),其次是拉丁美洲(58%)和欧洲(54%)的受访者。先前的研究表明,对艾滋病毒耐药性的充分了解与改善治疗依从性之间存在很强的相关性。在来自美国和西欧的ATLIS受访者中,美国受访者(13.3%)最不可能不知道自己的CD4计数,而德国受访者(43.6%)和意大利受访者(37.5%)最可能不知道自己的CD4计数。再加上关于卫生知识普及程度低对人类健康影响的大量现有文献,ATLIS的结果为从事艾滋病毒医学领域的广大社区敲响了警钟。通过已经探索的手段或包括创新方法在内的综合手段提高艾滋病毒知识普及程度,将转化为更大的治疗成功。但是,只有在开发更新、毒性更小的抗逆转录病毒药物的同时,将其列为优先事项,才能实现这一目标;通过消除阻碍进展的临床、经济和社会障碍,扩大获得抗逆转录病毒治疗的机会;以及进一步的整合
{"title":"Promoting HIV Literacy","authors":"J. Zuniga","doi":"10.1177/1545109708326073","DOIUrl":"https://doi.org/10.1177/1545109708326073","url":null,"abstract":"H ealth literacy has a significant impact on our daily lives, affecting almost every aspect of our ability to understand and process information regarding our health. According to the American Medical Association (AMA), poor health literacy is ‘‘a stronger predictor of a person’s health than age, income, employment status, education level, and race.’’ In Health Literacy: A Prescription to End Confusion, the Institute of Medicine (IOM) reported that 90 million people in the United States, nearly half the population, have difficulty understanding and using health information. As a result, patients often take medicines on erratic schedules, miss follow-up appointments, and/or do not understand instructions such as ‘‘take on an empty stomach.’’ There are various examples of low health literacy’s impact. For example, a study of 483 asthma patients found that although two thirds reported graduating from high school, only 60% could read above the sixth-grade level. Reading ability was the single strongest predictor of asthma knowledge. Twice as many patients reading below the third-grade level had poor metered-dose inhaler technique as patients reading at high-school level (89% vs. 48%). And in a study involving 659 public hospital patients, those with poor health literacy skills were 5 times more likely to misinterpret their prescriptions than those with adequate skills. Likewise, in the management of HIV disease, a patient’s level of HIV literacy is critical for treatment success, one of the most important predictors of which is levels of adherence to antiretroviral therapy. A study of 182 HIV-positive adults found that those with low health literacy were more likely to miss doses than those with high health literacy because of confusion about the instructions. Yet another study involving 204 HIV-positive patients showed that low HIV literacy doubled the likelihood of nonadherence to antiretroviral therapy. Low HIV literacy was also demonstrated in the recent AIDS Treatment for Life International Survey (ATLIS), the results of which were published in the July/August 2008 issue of the Journal of the International Association of Physicians in AIDS Care (JIAPAC). This multicountry survey of almost 3000 HIV-positive patients from 6 geographical regions identified some major gaps in HIV literacy. When respondents were asked to describe how HIV drug resistance develops, for example, only 17% accurately answered the question; a total of 54% answered incorrectly or did not know the answer and 29% provided only partially accurate answers. North American (48%) and Asian/Pacific (20%) respondents were most likely to select the correct answer to the question, whereas African respondents were more likely to select an inaccurate answer or did not know (79%), followed by respondents from Latin America (58%) and Europe (54%). Previous studies have shown a strong correlation between a good understanding of HIV drug resistance and improved treatment adherence. Among th","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"7 1","pages":"215 - 216"},"PeriodicalIF":0.0,"publicationDate":"2008-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109708326073","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Letter from the Editor-in-Chief 总编辑来信
Pub Date : 2008-05-01 DOI: 10.1177/1545109708319459
J. Zuniga
Among the many interesting articles in this issue of the Journal, I would like to bring to your attention the paper by Dr. Eisenberg and his colleagues entitled ‘‘Chronic Ambulatory Monitoring: Results of a Large Single-Center Experience’’. The authors evaluated the diagnostic yield of a wearable cardiac monitoring device. They reviewed data from 524 patients who were prescribed the monitor for a variety of indications including monitoring for atrial fibrillation and elucidating the mechanism of palpitations. This study resulted in many interesting findings the most important of which in my opinion is that the majority of atrial fibrillation episodes detected by the long-term monitoring device were asymptomatic.
在本期《华尔街日报》的许多有趣的文章中,我想提请大家注意艾森伯格博士和他的同事发表的题为“慢性动态监测:大型单中心经验的结果”的论文。作者评估了可穿戴心脏监测设备的诊断率。他们回顾了524名患者的数据,这些患者使用了监护仪来监测各种适应症,包括监测心房颤动和阐明心悸的机制。这项研究产生了许多有趣的发现,我认为最重要的是,通过长期监测装置检测到的大多数房颤发作是无症状的。
{"title":"Letter from the Editor-in-Chief","authors":"J. Zuniga","doi":"10.1177/1545109708319459","DOIUrl":"https://doi.org/10.1177/1545109708319459","url":null,"abstract":"Among the many interesting articles in this issue of the Journal, I would like to bring to your attention the paper by Dr. Eisenberg and his colleagues entitled ‘‘Chronic Ambulatory Monitoring: Results of a Large Single-Center Experience’’. The authors evaluated the diagnostic yield of a wearable cardiac monitoring device. They reviewed data from 524 patients who were prescribed the monitor for a variety of indications including monitoring for atrial fibrillation and elucidating the mechanism of palpitations. This study resulted in many interesting findings the most important of which in my opinion is that the majority of atrial fibrillation episodes detected by the long-term monitoring device were asymptomatic.","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"7 1","pages":"103 - 103"},"PeriodicalIF":0.0,"publicationDate":"2008-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109708319459","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NIMH/IAPAC International Conference on HIV Treatment Adherence NIMH/IAPAC艾滋病治疗依从性国际会议
Pub Date : 2006-06-01 DOI: 10.1177/154510970600500202
{"title":"NIMH/IAPAC International Conference on HIV Treatment Adherence","authors":"","doi":"10.1177/154510970600500202","DOIUrl":"https://doi.org/10.1177/154510970600500202","url":null,"abstract":"","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"5 1","pages":"57 - 82"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/154510970600500202","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65511063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NIMH/IAPAC International Conference on HIV Treatment Adherence NIMH/IAPAC艾滋病治疗依从性国际会议
Pub Date : 2006-03-01 DOI: 10.1177/1545109706287005
{"title":"NIMH/IAPAC International Conference on HIV Treatment Adherence","authors":"","doi":"10.1177/1545109706287005","DOIUrl":"https://doi.org/10.1177/1545109706287005","url":null,"abstract":"","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"5 1","pages":"29 - 39"},"PeriodicalIF":0.0,"publicationDate":"2006-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109706287005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NIMH/IAPAC International Conference on HIV Treatment Adherence NIMH/IAPAC艾滋病治疗依从性国际会议
Pub Date : 2006-03-01 DOI: 10.1177/1545109706287006
{"title":"NIMH/IAPAC International Conference on HIV Treatment Adherence","authors":"","doi":"10.1177/1545109706287006","DOIUrl":"https://doi.org/10.1177/1545109706287006","url":null,"abstract":"","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"5 1","pages":"11 - 28"},"PeriodicalIF":0.0,"publicationDate":"2006-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109706287006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Submission Guidelines for Contributors 投稿指南
Pub Date : 2005-07-01 DOI: 10.1177/154510970500400301
{"title":"Submission Guidelines for Contributors","authors":"","doi":"10.1177/154510970500400301","DOIUrl":"https://doi.org/10.1177/154510970500400301","url":null,"abstract":"","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"4 1","pages":"56 - 57"},"PeriodicalIF":0.0,"publicationDate":"2005-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/154510970500400301","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Management, Consistent Focus 新的管理,始终如一的焦点
Pub Date : 2005-04-01 DOI: 10.1177/1545109705279845
J. Bartlett, P. Mugyenyi
{"title":"New Management, Consistent Focus","authors":"J. Bartlett, P. Mugyenyi","doi":"10.1177/1545109705279845","DOIUrl":"https://doi.org/10.1177/1545109705279845","url":null,"abstract":"","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"4 1","pages":"31 - 31"},"PeriodicalIF":0.0,"publicationDate":"2005-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109705279845","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65511031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Select Abstracts from Elements of Success 2004: An International Conference on Adherence to Antiretroviral Therapy 摘自2004年成功要素:坚持抗逆转录病毒治疗国际会议摘要
Pub Date : 2004-10-01 DOI: 10.1177/154510970400300404
Ross M. Hewitt
Background: While the notion of a “dose” is a basic construct in treatment research and practice, neither the parameters used to characterize a missed dose, nor what should be done to correct a missed dose and maintain adherence are widely shared by patients, nor agreed upon between clinicians and patients. This study examines clinician and patient understandings of the parameters of a missed dose and of what should be done when a dose is missed. Methods: Sixty African Americans taking [highly active antiretroviral therapy (HAART)] (20 women, 40 men) and 20 of their physicians and nurses, all of whom are enrolled in a longitudinal study on HAART adherence, were interviewed. Measures included: self-definition of a medication dose, missed dose, and corrective actions; adherence (CPCRA three-day pilltaking recall, three-month self assessment, Medical Outcomes Study adherence scale [Kravitz et al, 1993] and a visual analogue), and biomarkers of adherence (viral load and CD4 counts). Open-ended interviews and standardized techniques were used. Results: We found consistent systematic definitions of a missed dose and of dose management. Three definitions marking different sets of parameters for a missed dose were identified: medication not taken at the exactly same time every day (15 percent of clinicians, 20 percent of patients); medication taken outside a threeto four-hour window each day (75 percent of clinicians, 60 percent of patients); medication not taken some time within the waking day (10 percent of clinicians, 20 percent of patients). Clinicians and patients agreed that one should not double up on doses to make up for a missed dose but expressed a range of acceptable means to address a missed dose. Conclusions: Efforts to refine the measurement of HAART adherence need to be aware of the threats to validity posed by the range of working definitions of a missed dose. 2 – Adaptive Poisson regression analysis of MEMS adherence data
背景:虽然“剂量”的概念是治疗研究和实践中的一个基本概念,但用于表征漏给剂量的参数,以及纠正漏给剂量和维持依从性的措施都没有被患者广泛共享,也没有在临床医生和患者之间达成一致。本研究考察了临床医生和患者对漏给剂量参数的理解,以及漏给剂量时应采取的措施。方法:对60名接受高效抗逆转录病毒治疗(HAART)的非裔美国人(20名女性,40名男性)及其20名医生和护士进行访谈,所有这些人都参加了一项关于HAART依从性的纵向研究。措施包括:自我定义用药剂量、漏给剂量和纠正措施;依从性(CPCRA三天服药召回,三个月自我评估,医学结局研究依从性量表[Kravitz等,1993]和视觉模拟),以及依从性的生物标志物(病毒载量和CD4计数)。采用开放式访谈和标准化技术。结果:我们发现了漏报剂量和剂量管理的一致的系统定义。确定了三种定义,标记了错过剂量的不同参数集:每天没有在完全相同的时间服用药物(15%的临床医生,20%的患者);每天在三到四个小时的时间之外服用药物(75%的临床医生,60%的患者);在清醒的一天中没有服用药物(10%的临床医生,20%的患者)。临床医生和患者一致认为,不应该加倍剂量来弥补错过的剂量,但表达了一系列可接受的方法来解决错过的剂量。结论:改进HAART依从性测量的努力需要意识到错过剂量的工作定义范围对有效性构成的威胁。2 - MEMS黏附数据的自适应泊松回归分析
{"title":"Select Abstracts from Elements of Success 2004: An International Conference on Adherence to Antiretroviral Therapy","authors":"Ross M. Hewitt","doi":"10.1177/154510970400300404","DOIUrl":"https://doi.org/10.1177/154510970400300404","url":null,"abstract":"Background: While the notion of a “dose” is a basic construct in treatment research and practice, neither the parameters used to characterize a missed dose, nor what should be done to correct a missed dose and maintain adherence are widely shared by patients, nor agreed upon between clinicians and patients. This study examines clinician and patient understandings of the parameters of a missed dose and of what should be done when a dose is missed. Methods: Sixty African Americans taking [highly active antiretroviral therapy (HAART)] (20 women, 40 men) and 20 of their physicians and nurses, all of whom are enrolled in a longitudinal study on HAART adherence, were interviewed. Measures included: self-definition of a medication dose, missed dose, and corrective actions; adherence (CPCRA three-day pilltaking recall, three-month self assessment, Medical Outcomes Study adherence scale [Kravitz et al, 1993] and a visual analogue), and biomarkers of adherence (viral load and CD4 counts). Open-ended interviews and standardized techniques were used. Results: We found consistent systematic definitions of a missed dose and of dose management. Three definitions marking different sets of parameters for a missed dose were identified: medication not taken at the exactly same time every day (15 percent of clinicians, 20 percent of patients); medication taken outside a threeto four-hour window each day (75 percent of clinicians, 60 percent of patients); medication not taken some time within the waking day (10 percent of clinicians, 20 percent of patients). Clinicians and patients agreed that one should not double up on doses to make up for a missed dose but expressed a range of acceptable means to address a missed dose. Conclusions: Efforts to refine the measurement of HAART adherence need to be aware of the threats to validity posed by the range of working definitions of a missed dose. 2 – Adaptive Poisson regression analysis of MEMS adherence data","PeriodicalId":81716,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care","volume":"3 1","pages":"130 - 143"},"PeriodicalIF":0.0,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/154510970400300404","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65510841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the International Association of Physicians in AIDS Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1